bullish
Japan’s Astellas Pharma Buys US-Based Xyphos Biosciences Inc.
531 Views30 Dec 2019 14:01
It was reported by Reuters and several other media that the Japan-based Astellas Pharma has bought the US-based Xyphos Bioscience Inc. in a deal...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- M3 Inc: M&A Deals to Support Global Expansion While Medical Platform Offers Solid LT Growth27 Mar 2020
- Fujifilm’s Shares Hit Daily Upper Limit on COVID Trial Drug Boost18 Mar 2020
- Japan’s AGC Launches Voluntary Tender Offer on Italian Biotech Firm Molmed18 Mar 2020
- Japan’s Astellas Pharma to Buy Audentes Therapeutics to Expand into Gene Therapy Market04 Dec 2019
x